Optimus Healthcare Services, Inc.

OTCPK:OHCS Stock Report

Market Cap: US$3.5m

Optimus Healthcare Services Valuation

Is OHCS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OHCS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate OHCS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate OHCS's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OHCS?

Key metric: As OHCS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for OHCS. This is calculated by dividing OHCS's market cap by their current revenue.
What is OHCS's PS Ratio?
PS Ratio0.9x
SalesUS$1.82m
Market CapUS$3.45m

Price to Sales Ratio vs Peers

How does OHCS's PS Ratio compare to its peers?

The above table shows the PS ratio for OHCS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
GBNH.F Greenbrook TMS
0.04xn/aUS$2.6m
XCRT Xcelerate
4.5xn/aUS$9.9m
SYRA Syra Health
0.8xn/aUS$6.5m
CMAX CareMax
0.004x26.0%US$2.5m
OHCS Optimus Healthcare Services
0.9xn/aUS$3.5m

Price-To-Sales vs Peers: OHCS is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.3x).

Price to Sales Ratio vs Industry

How does OHCS's PS Ratio compare vs other companies in the US Healthcare Industry?

30 CompaniesPrice / SalesEstimated GrowthMarket Cap
MCK McKesson
0.2x8.1%US$79.75b
CVS CVS Health
0.2x4.6%US$71.86b
COR Cencora
0.2x6.4%US$48.16b
CNC Centene
0.2x5.5%US$30.47b
OHCS 0.9xIndustry Avg. 1.0xNo. of Companies30PS012345+
30 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: OHCS is good value based on its Price-To-Sales Ratio (0.9x) compared to the US Healthcare industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is OHCS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OHCS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate OHCS's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Elevance Health

US$93.6b

Operates as a health benefits company in the United States.

ELV

US$402.55

7D

0.5%

1Y

-15.9%

Centene

US$30.5b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

CNC

US$60.37

7D

5.1%

1Y

-18.8%

electroCore

US$64.0m

A commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.

ECOR

US$11.21

7D

2.5%

1Y

101.6%